abstract |
A composition including a CXCR4 antagonist and a CCR5 antagonist represented by formula I or II: n nor an acceptable salt, solvate or ester thereof. The CXCR4 antagonist includes at least one of AMD-070, CS-3955, KRH-1120, KRH-2731, and KRH-1636. |